Best Weight Loss Injections for Women in 2026 — Ranked & Reviewed
Semaglutide and tirzepatide are not gender-specific drugs, so the medication itself is identical whoever takes it. The program wrapped around it is what differs. In trial data, women lose weight on GLP-1s at rates equal to or a little above men's, and the questions that genuinely change which provider suits you are PCOS, perimenopause, how tirzepatide interacts with birth control, and pregnancy planning. Ranked below are injectable GLP-1 providers with real depth on exactly that: menopause-certified clinicians, programs that account for PCOS, and platforms built around women's care.
Lowest verified price: $79/mo14 providers compared
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
14 weight loss injections for women compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
knowing which pharmacy fills the vial: it names RedRock Pharmacy
From /mo$79Coverage50 statesMedicationsSemaglutideTirzepatide - Nationwide Coverage
tirzepatide at $169/month, 37% below the typical price
From /mo$99Coverage50 statesMedicationsSemaglutideTirzepatide seeing what it charges before you answer any medical questions
From /mo$299Coverage35 statesMedicationsSemaglutideTirzepatide
Show 5 moreShow fewer
semaglutide at $100/month, 47% below the typical price
From /mo$100Coverage45 statesMedicationsSemaglutidestarting below a standard dose, with microdose tiers
From /mo$79CoverageCheck intakeMedicationsSemaglutideTirzepatide- Best Care Team
coaching bundled into the price rather than sold separately
From /mo$139Coverage50 statesMedicationsSemaglutideTirzepatide knowing which pharmacy fills the vial: it names Triad Rx
From /mo$99Coverage48 statesMedicationsSemaglutideTirzepatide- Best Budget
an oral route if you will not self-inject
From /mo$54Coverage39 statesMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick knowing which pharmacy fills the vial: it names RedRock Pharmacy | $79 | SemaglutideTirzepatide | 50 states | Visit → | |
Nationwide Coverage tirzepatide at $169/month, 37% below the typical price | $99 | SemaglutideTirzepatide | 50 states | Visit → | |
 seeing what it charges before you answer any medical questions | $299 | SemaglutideTirzepatide | 35 states | Visit → | |
 semaglutide at $100/month, 47% below the typical price | $100 | Semaglutide | 45 states | Visit → | |
 starting below a standard dose, with microdose tiers | $79 | SemaglutideTirzepatide | Check intake | Visit → | |
Best Care Team coaching bundled into the price rather than sold separately | $139 | SemaglutideTirzepatide | 50 states | Visit → | |
 knowing which pharmacy fills the vial: it names Triad Rx | $99 | SemaglutideTirzepatide | 48 states | Visit → | |
Best Budget an oral route if you will not self-inject | $54 | SemaglutideTirzepatide | 39 states | Visit → |
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
Detailed Reviews
Embody
Verified partnerBest for: knowing which pharmacy fills the vial: it names RedRock Pharmacy
Embody sells compounded semaglutide and tirzepatide by injection, plus a compounded oral tirzepatide gum that is unique in the category. Flat-rate pricing is aggressive, coverage runs to all 50 states, and clinician messaging is available 24/7 under a board-certified internal medicine CMO.
Score Breakdown
Pros
- ✓Semaglutide costs $79 a month, 57% below the $185 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $129 a month, 48% below the $250 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Serves all 50 states
- ✓Names 4 pharmacies that fill its prescriptions, which most sellers do not
- ✓We found no FDA warning letters issued to Embody
- ✓Offers both oral and injectable options, so the format is your choice
Cons
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Found
Verified partnerBest for: tirzepatide at $169/month, 37% below the typical price
Found is a personalized weight care platform. It runs on a self-pay membership, and medication costs sit on top of that.
Score Breakdown
Pros
- ✓Tirzepatide costs $169 a month, 32% below the $250 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes the medication, clinician visits and coaching
- ✓Serves all 50 states
- ✓We found no FDA warning letters issued to Found
Cons
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its orforglipron, semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Willow
Verified partnerBest for: seeing what it charges before you answer any medical questions
Score breakdown, pros and cons
Tablets and injections are both on offer at Willow, a telehealth seller of compounded GLP-1 medications.
Score Breakdown
Pros
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Names 5 pharmacies that fill its prescriptions, which most sellers do not
- ✓We found no FDA warning letters issued to Willow
Cons
- ✗Serves only 35 states, so check that yours is one of them
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Queen RX
Best for: semaglutide at $100/month, 47% below the typical price
Score breakdown, pros and cons
Queen RX charges $299 per quarter, roughly $100/mo, for compounded GLP-1 treatment covering semaglutide, tirzepatide and liraglutide. It sells in 45 states; KS, LA, MS, NM and WV are excluded.
Score Breakdown
Pros
- ✓Semaglutide costs $100 a month, 46% below the $185 median for compounded semaglutide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes the medication and clinician visits
- ✓Serves 45 states
- ✓We found no FDA warning letters issued to Queen RX
Cons
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Good Girl Rx
Best for: starting below a standard dose, with microdose tiers
Score breakdown, pros and cons
Savannah Chrisley founded Good Girl Rx, registered as Good Girl LLC. Compounded semaglutide and tirzepatide come three ways: injectable, microdose, and oral dissolving tablet (ODT). Availability on the brand names, Mounjaro, Zepbound, Wegovy, and Ozempic, is limited, though all four are listed. Licensed 503A/503B pharmacies dispense, and the company holds LegitScript certification.
Score Breakdown
Pros
- ✓Semaglutide costs $79 a month, 57% below the $185 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $139 a month, 44% below the $250 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
- ✓Offers both oral and injectable options, so the format is your choice
Cons
- ✗Confirm it serves your state before you start the intake
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗The FDA has issued Good Girl Rx a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What a woman should check on a GLP-1 seller
Sex does not change the medication. It does change what competent care around the medication looks like. Depth on PCOS, on menopause, and on pregnancy planning is where the sellers on this page separate from one another.
What to check
- Hormonal health, covered or not. Weight and GLP-1 response both shift with PCOS and with perimenopause. Some sellers staff menopause-certified clinicians, or run a program written with PCOS in mind. A generic telehealth intake collects none of that information and so cannot act on it.
- Birth control and pregnancy in the intake. Oral contraception can be made less effective by tirzepatide, and a GLP-1 has to be stopped ahead of a pregnancy. Both facts belong in the intake form. Where they appear in a footnote instead, or nowhere, no screening happened.
- Anything addressing lean mass. Lean tissue leaves alongside fat when loss is fast. Protein targets and resistance training are how that is limited. Some sellers build both into the program and others ship the drug by itself.
Red flags
- Pharmacy unnamed and no LegitScript listing. Two disclosures are checkable on any compounded-GLP-1 seller: the 503A or 503B pharmacy filling the vial, and a LegitScript certification. When a site publishes neither, nothing about the contents of that vial can be confirmed from outside.
- Instant approval with no clinician you can reach. A prescriber is supposed to read the intake and stay available once dose questions start. Approval issued automatically, with nobody reachable afterward, means the medical layer was removed rather than streamlined.
- The advertised number is a first month. Headline figures here are usually qualified somewhere. Common forms are an opening rate that steps up with each dose increase, and a membership fee billed separately from the drug itself. Either one can double what leaves your account in month two.
- B12, MIC, or HCG sold for weight loss. Trial evidence for weight loss sits with the GLP-1 injections and nowhere else on this aisle. A clinic that lists lipotropic, B12, or HCG shots under weight loss is selling past the record, whatever its own site says.
Every seller listed above is scored on these criteria under our six-dimension methodology, with prices re-checked against the seller’s own live site.
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Frequently Asked Questions
Sources & methodology — as of September 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.